Scarica l'app Stockscreener
3.21
4.46%
-0.15
Dopo l'orario di chiusura:
3.22
0.01
+0.31%
Precedente Chiudi:
$3.36
Aprire:
$3.28
Volume 24 ore:
40,554
Relative Volume:
0.33
Capitalizzazione di mercato:
$37.58M
Reddito:
-
Utile/perdita netta:
$-19.25M
Rapporto P/E:
-1.8034
EPS:
-1.78
Flusso di cassa netto:
$-17.87M
1 W Prestazione:
-9.32%
1M Prestazione:
-19.14%
6M Prestazione:
-3.31%
1 anno Prestazione:
+1.58%
Intervallo 1D:
$3.1579
$3.3865
Intervallo di 1 settimana:
$3.1579
$3.70
Portata 52W:
$2.55
$6.118
Lantern Pharma Inc Stock (LTRN) Company Profile
Nome
Lantern Pharma Inc
Settore
Industria
Telefono
972-277-1136
Indirizzo
1920 MCKINNEY AVENUE, DALLAS, TX
Confronta LTRN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LTRN
Lantern Pharma Inc
|
3.21 | 37.58M | 0 | -19.25M | -17.87M | -1.78 |
|
ARGX
Argen X Se Adr
|
918.53 | 57.24B | 3.06B | 1.28B | 447.35M | 19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.52 | 110.12B | 11.74B | 3.68B | 3.34B | 14.19 |
|
INSM
Insmed Inc
|
201.62 | 42.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
ONC
Beone Medicines Ltd Adr
|
363.92 | 41.68B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
REGN
Regeneron Pharmaceuticals Inc
|
725.34 | 74.02B | 14.25B | 4.58B | 3.88B | 41.77 |
Lantern Pharma Inc Stock (LTRN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-10-07 | Iniziato | H.C. Wainwright | Buy |
Lantern Pharma Inc Borsa (LTRN) Ultime notizie
Is Lantern Pharma Inc. stock vulnerable to regulatory risksJuly 2025 Technicals & High Accuracy Trade Signal Alerts - newser.com
Is Lantern Pharma Inc. stock oversold or undervaluedTrade Signal Summary & Risk Managed Investment Strategies - newser.com
How Lantern Pharma Inc. stock reacts to global recession fearsEarnings Overview Summary & Reliable Price Breakout Alerts - newser.com
How Lantern Pharma Inc. stock performs in weak economyQuarterly Market Summary & Weekly Stock Breakout Alerts - newser.com
Lantern Pharma Engages New to The Street for National Media Coverage Featuring Television, Press, Earned Media and Non-Deal Investor Focused Roadshows - Gadsden Times
Using economic indicators to assess Lantern Pharma Inc. potentialQuarterly Trade Report & Daily Stock Trend Reports - newser.com
Can Lantern Pharma Inc. stock deliver consistent earnings growthMarket Sentiment Report & AI Forecast for Swing Trade Picks - newser.com
Lantern Pharma (NASDAQ:LTRN) Will Have To Spend Its Cash Wisely - Yahoo Finance
Lantern Pharma Inc. (NASDAQ:LTRN) Q3 2025 Earnings Call Transcript - Insider Monkey
Lantern Pharma’s Earnings Call: Progress and Funding Needs - TipRanks
Lantern Pharma’s Q3 2025: Clinical and AI Progress - TipRanks
Lantern Pharma (NASDAQ: LTRN) Reports Q3 2025 Results and Highlights AI-Driven Clinical Progress - Digital Journal
Transcript : Lantern Pharma Inc., Q3 2025 Earnings Call, Nov 13, 2025 - MarketScreener
Will Lantern Pharma Inc. stock maintain dividend yieldBreakout Watch & Free Risk Controlled Daily Trade Plans - newser.com
LTRN: Pivotal quarter with clinical milestones, AI platform advances, and cash runway into Q3 2026 - TradingView
Earnings call transcript: Lantern Pharma Q3 2025 sees stock rise after earnings - Investing.com India
Lantern Pharma : Q3 2025 Earnings Call - MarketScreener
Lantern Pharma Achieves Key Milestones in Q3 2025 - TipRanks
Lantern Pharma Reports Third Quarter 2025 Financial Results and Provides Business Updates - Business Wire
Full technical analysis of Lantern Pharma Inc. stock2025 Short Interest & Community Consensus Picks - newser.com
Lantern Pharma Earnings Preview - Benzinga
Lake Street Schedules Virtual Meeting for November 20 with LTRN Focus - GuruFocus
Lantern Pharma Q3 2025 Earnings Call Transcript - MarketBeat
How Lantern Pharma Inc. stock reacts to oil pricesMarket Risk Report & Daily Stock Momentum Reports - newser.com
Is Lantern Pharma Inc. stock a buy before product launchesJuly 2025 Catalysts & Safe Investment Capital Preservation Plans - newser.com
Lantern Pharma (NASDAQ: LTRN) CEO Discusses AI-Driven Cancer Drug Development in FintechTV Interview at NYSE - Digital Journal
Lantern Pharma Inc. stock trendline breakdownEarnings Summary Report & Community Trade Idea Sharing - newser.com
Is Lantern Pharma Inc. stock attractive for income investorsWatch List & Stepwise Trade Signal Guides - newser.com
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Lancaster Eagle-Gazette
Lantern Pharma (LTRN) Partners with New to The Street for Extens - GuruFocus
Lantern Pharma Inc Azioni (LTRN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.08%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):